{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:35Z","timestamp":1707524735997},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,9]]},"DOI":"10.7759\/cureus.31310","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T07:09:02Z","timestamp":1668064142000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 Vaccine: A Common Suspect but Rare Culprit in Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome"],"prefix":"10.7759","author":[{"given":"Mary","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19223","article-title":"Drug reaction with eosinophilia and systemic symptom (DRESS) following rifampicin treatment: a case report","volume":"13","author":"Shrestha R","year":"2021","unstructured":"Shrestha R, Jha SK, Bartaula J. Drug reaction with eosinophilia and systemic symptom (DRESS) following rifampicin treatment: a case report. Cureus. 2021, 13:e19223. 10.7759\/cureus.19223","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol. 2013, 68:693.e1-14; quiz 706-8. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.02.2011.3898","article-title":"DRESS syndrome: a case report and literature review","volume":"2011","author":"Cardoso CS","year":"2011","unstructured":"Cardoso CS, Vieira AM, Oliveira AP. DRESS syndrome: a case report and literature review. BMJ Case Rep. 2011, 2011:10.1136\/bcr.02.2011.3898","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen YC","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010, 146:1373-9. 10.1001\/archdermatol.2010.198","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.177777","article-title":"Levetiracetam induced drug reaction with eosinophilia and systemic symptom syndrome","volume":"61","author":"Dar WR","year":"2016","unstructured":"Dar WR, Sofi N, Latief M, Dar IA, Kasana BA. Levetiracetam induced drug reaction with eosinophilia and systemic symptom syndrome. Indian J Dermatol. 2016, 61:235. 10.4103\/0019-5154.177777","journal-title":"Indian J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2017.28.218.10828","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6-year-old boy: a case report","volume":"28","author":"Karakayal\u0131 B","year":"2017","unstructured":"Karakayal\u0131 B, Yazar AS, \u00c7akir D, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6-year-old boy: a case report. Pan Afr Med J. 2017, 28:218. 10.11604\/pamj.2017.28.218.10828","journal-title":"Pan Afr Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration adverse event reporting system","volume":"9","author":"Bluestein SB","year":"2021","unstructured":"Bluestein SB, Yu R, Stone C Jr, Phillips EJ. Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration adverse event reporting system. J Allergy Clin Immunol Pract. 2021, 9:3208-3211.e1. 10.1016\/j.jaip.2021.05.008","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234251","article-title":"DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction","volume":"13","author":"Mukit W","year":"2020","unstructured":"Mukit W, Cooper R, Moudgil H, Ahmad N. DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction. BMJ Case Rep. 2020, 13:10.1136\/bcr-2020-234251","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps V","year":"2014","unstructured":"Descamps V, Ranger-Rogez S. DRESS syndrome. Joint Bone Spine. 2014, 81:15-21. 10.1016\/j.jbspin.2013.05.002","journal-title":"Joint Bone Spine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"6","author":"Kim DH","year":"2014","unstructured":"Kim DH, Koh YI. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Immunol Res. 2014, 6:216-21. 10.4168\/aair.2014.6.3.216","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1297422","article-title":"Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"13","author":"Shiohara T","year":"2017","unstructured":"Shiohara T, Kano Y, Hirahara K, Aoyama Y. Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS). Expert Opin Drug Metab Toxicol. 2017, 13:701-4. 10.1080\/17425255.2017.1297422","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","volume":"10","author":"Schunkert EM","year":"2021","unstructured":"Schunkert EM, Divito SJ. Updates and insights in the diagnosis and management of DRESS syndrome. Curr Dermatol Rep. 2021, 10:192-204. 10.1007\/s13671-021-00348-z","journal-title":"Curr Dermatol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16347","article-title":"Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines","volume":"49","author":"Korekawa A","year":"2022","unstructured":"Korekawa A, Nakajima K, Fukushi K, Nakano H, Sawamura D. Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines. J Dermatol. 2022, 49:652-5. 10.1111\/1346-8138.16347","journal-title":"J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.11.028","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine","volume":"20","author":"O'Connor T","year":"2022","unstructured":"O'Connor T, O'Callaghan-Maher M, Ryan P, Gibson G. Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine. JAAD Case Rep. 2022, 20:14-6. 10.1016\/j.jdcr.2021.11.028","journal-title":"JAAD Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.05.010","article-title":"A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine","volume":"13","author":"Lospinoso K","year":"2021","unstructured":"Lospinoso K, Nichols CS, Malachowski SJ, Mochel MC, Nutan F. A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine. JAAD Case Rep. 2021, 13:134-7. 10.1016\/j.jdcr.2021.05.010","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120013-covid-19-vaccine-a-common-suspect-but-rare-culprit-in-drug-rash-with-eosinophilia-and-systemic-symptoms-dress-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:37Z","timestamp":1707507697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120013-covid-19-vaccine-a-common-suspect-but-rare-culprit-in-drug-rash-with-eosinophilia-and-systemic-symptoms-dress-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.31310","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}